Home / Tag Archives: diabetes monitoring

Tag Archives: diabetes monitoring

A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?

Clinician reviewing A1C and glycated albumin results for type 2 diabetes monitoring

A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …

Read More »

A Positive Type 1 Diabetes Screen Isn’t Always Equal: Why IA-2 Changes the Risk Calculation

Clinical illustration showing IA-2 autoantibody testing, type 1 diabetes risk assessment, blood sample analysis, and patient monitoring strategies used in islet autoantibody screening risk stratification.

As population-based screening for type 1 diabetes (T1D) becomes more common, clinicians increasingly encounter positive islet autoantibody results in children and adults who have no symptoms. However, not all positive screening results carry the same clinical significance. A single positive autoantibody may indicate elevated risk, yet the specific antibody detected …

Read More »

Post-Meal Blood Sugar Spikes: Are We Focusing on the Wrong Diabetes Numbers?

Healthy diabetes management scene showing a glucose meter, nutritious meal, and post-meal blood sugar tracking chart illustrating postprandial glucose control.

For decades, A1C has served as the cornerstone of diabetes management. It remains an essential marker because it reflects average blood glucose levels over approximately three months. However, many clinicians are recognizing that managing post-meal glucose levels may provide equally important insights into a patient’s metabolic health. A person can …

Read More »

GLP-1 Therapy and Diagnostic Drift: Are We Masking Disease Progression?

GLP-1 injection pen with HbA1c test tubes and pancreas model illustrating hidden diabetes disease progression

Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …

Read More »